Stephen E. de Laszlo

Statistics

Publications

Citations

1.4K

H-Index

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Stephen E. de Laszlo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and receptor pharmacology.

Publications per year

1984–2004

Publications

Potent, orally absorbed glucagon receptor antagonists

Stephen E. de Laszlo, Candice Hacker, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 169 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Pyrroles and other heterocycles as inhibitors of P38 kinase

Stephen E. de Laszlo, Denise M. Visco, Lily Agarwal et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor

Stephen E. de Laszlo, Carol S. Quagliato, William J. Greenlee et al. · Journal of Medicinal Chemistry · 1993 · 113 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Substituted Imidazoles as Glucagon Receptor Antagonists

Linda L. Chang, Kelly L. Sidler, Margaret A. Cascieri et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Molecular Basis for p38 Protein Kinase Inhibitor Specificity

JeanMarie Lisnock, Andy Tebben, Betsy Frantz et al. · Biochemistry · 1998 · 95 citations

Life Sciences, Molecular Biology, Pharmacology +13

1–5 of 29